Citations (82)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Jian Zhou, Xiaoke Zhu, Yue Yang, Liang Zhou, Hongli Gong, Chengzhi Xu & Lei Tao. (2023) Predictive value of pathological carcinoma size in patients with T2 glottic laryngeal squamous cell carcinoma. Acta Oto-Laryngologica 143:4, pages 323-327.
Read now
Read now
N. Tsoukalas, E. Mosa, K. Tsapakidis, K. Kamposioras & M. Tolia. (2021) Primary Gross Tumor Volume (pGTV) and Tumor Response in Locally Advanced Rectal Cancer (LARC). Is There Any Correlation?. Journal of Investigative Surgery 34:2, pages 191-193.
Read now
Read now
Wenxue Liu, Yuqiang Li, Hong Zhu, Qian Pei, Fengbo Tan, Xiangping Song, Zhongyi Zhou, Yuan Zhou, Dan Wang & Haiping Pei. (2021) The Relationship between Primary Gross Tumor Volume and Tumor Response of Locally Advanced Rectal Cancer: pGTV as a More Accurate Tumor Size Indicator. Journal of Investigative Surgery 34:2, pages 181-190.
Read now
Read now
Izabela Kordzińska-Cisek, Paweł Cisek & Ludmiła Grzybowska-Szatkowska. (2020) The Role of Prognostic Factors in Salivary Gland Tumors Treated by Surgery and Adjuvant Radio- or Chemoradiotherapy – A Single Institution Experience. Cancer Management and Research 12, pages 1047-1067.
Read now
Read now
Kelly M. Quesnelle, Sarah E. Wheeler, Mary K. Ratay & Jennifer R. Grandis. (2012) Preclinical modeling of EGFR inhibitor resistance in head and neck cancer. Cancer Biology & Therapy 13:10, pages 935-945.
Read now
Read now
Young Mi Seol, Bo Ran Kwon, Moo Kon Song, Young Jin Choi, Ho Jin Shin, Joo Seop Chung, Goon Jae Cho, Jin Chun Lee, Byung Joo Lee, Soo Geun Wang, Hak Jin Kim, Won Taek Kim, Seung Jang Kim & Eun Young Yun. (2010) Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy. Acta Oncologica 49:2, pages 201-208.
Read now
Read now
Articles from other publishers (76)
Hannah Zaryouh, Ines De Pauw, Hasan Baysal, Jöran Melis, Valentin Van den Bossche, Christophe Hermans, Ho Wa Lau, Hilde Lambrechts, Céline Merlin, Cyril Corbet, Marc Peeters, Jan Baptist Vermorken, Jorrit De Waele, Filip Lardon & An Wouters. (2023) Establishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity. Cancer Drug Resistance 6:4, pages 709-28.
Crossref
Crossref
Julie Kjems, Katrin Elisabet Håkansson, Claus Andrup Kristensen, Jesper Grau Eriksen, Morten Horsholt Kristensen, Anne Ivalu Sander Holm, Jens Overgaard, Christian Rønn Hansen, Ruta Zukauskaite, Jørgen Johansen, Ivan Richter Vogelius & Jeppe Friborg. (2023) The influence of tumor volume on the risk of distant metastases in head and neck squamous cell carcinomas. Radiotherapy and Oncology 186, pages 109771.
Crossref
Crossref
Krishna S. Hanubal, Zhanna Galochkina, Ji‐Hyun Lee, Marna A. List, Tara C. Massini, Dustin Conrad, Brian Hughley, Deepa Danan, Reordan DeJesus, Kathryn Hitchcock, Spencer Nichols, William Mendenhall & Peter T. Dziegielewski. (2023) Tumor volume as a predictor of survival in advanced laryngeal cancer treated with total laryngectomy. Head & Neck 45:6, pages 1376-1388.
Crossref
Crossref
Yılmaz Özkul, Akif İşlek, Asuman Feda Bayrak, Ecem Akdağ & Demet Etit. (2023) Tumor Volume Staging Provides a Comparable Stratifying for Laryngeal Squamous Cell Cancer According to T Stages. Indian Journal of Otolaryngology and Head & Neck Surgery.
Crossref
Crossref
Imtiaz Ahmed, Sapna Krishnamurthy & Kumar Vinchurkar. (2023) Prognosticating Gross Tumor Volume in Head-and-Neck Cancer – Redefining Gross Tumor Volume Beyond Contouring. Journal of Medical Physics 48:1, pages 68.
Crossref
Crossref
Radka Lohynska, Michaela Jirkovska, Bela Malinova, Alena Novakova-Jiresova, Zdenka Pechacova & Zuzana Kratka. (2022) Tumour volume and radiotherapy prolongation in locally advanced head and neck cancer patients treated with radical IMRT. Biomedical Papers 166:4, pages 405-411.
Crossref
Crossref
Gabriel Adrian, Henrik Carlsson, Elisabeth Kjellén, Johanna Sjövall, Björn Zackrisson, Per Nilsson & Maria Gebre-Medhin. (2022) Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy. Radiation Oncology 17:1.
Crossref
Crossref
Ryan M. Murphy, Jason Tasoulas, Alessandro Porrello, Miranda B. Carper, Yi-Hsuan Tsai, Alisha R. Coffey, Sunil Kumar, Peter YF. Zeng, Travis P. Schrank, Bentley R. Midkiff, Stephanie Cohen, Ashley H. Salazar, Michele C. Hayward, D. Neil Hayes, Andrew Olshan, Gaorav P. Gupta, Anthony C. Nichols, Wendell G. Yarbrough, Chad V. Pecot & Antonio L. Amelio. (2022) Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer. Cancer Research Communications 2:9, pages 987-1004.
Crossref
Crossref
Elena Russo, Remo Accorona, Oreste Iocca, Andrea Costantino, Luca Malvezzi, Fabio Ferreli, Ciro Franzese, Marta Scorsetti, Pasquale Capaccio, Giuseppe Mercante, Giuseppe Spriano & Armando De Virgilio. (2022) Does Tumor Volume Have a Prognostic Role in Oropharyngeal Squamous Cell Carcinoma? A Systematic Review and Meta-Analysis. Cancers 14:10, pages 2465.
Crossref
Crossref
Gerda M Verduijn, Marta E Capala, Nienke D Sijtsema, Iris Lauwers, Juan A Hernandez Tamames, Wilma D Heemsbergen, Aniel Sewnaik, Jose A Hardillo, Hetty Mast, Yvette van Norden, Maurice P H M Jansen, Aad van der Lugt, Dik C van Gent, Mischa S Hoogeman, Bianca Mostert & Steven F Petit. (2022) The COMPLETE trial: HolistiC early respOnse assessMent for oroPharyngeaL cancEr paTiEnts; Protocol for an observational study. BMJ Open 12:5, pages e059345.
Crossref
Crossref
Jefferson Rijo‐Cedeño, Jorge Mucientes, Sara Seijas Marcos, Jesús Romero, Ana Royuela, Sandra Carbonell, Raquel Benlloch & José Ramón García‐Berrocal. (2021) Adding value to tumor staging in head and neck cancer: The role of metabolic parameters as prognostic factors. Head & Neck 43:8, pages 2477-2487.
Crossref
Crossref
Natália Martins Magacho de Andrade, Rogério Aparecido Dedivitis, Daniel Marin Ramos, Leandro Luongo Matos, Marcio Ricardo Taveira Garcia, Gustavo Gonçalves Conti & Luiz Paulo Kowalski. (2020) Tumor volume as a prognostic factor of locally advanced laryngeal cancer. European Archives of Oto-Rhino-Laryngology 278:5, pages 1627-1635.
Crossref
Crossref
Shwetabh Sinha, Jai Prakash Agarwal, Abhishek Mahajan, Pankaj Chaturvedi, Arun Balaji, Shashikant Juvekar, Tejpal Gupta, Ashwini Budrukkar, Vedang Murthy, Naveen Mummudi, Monali Swain, Rakesh Jadhav & Sarbani Ghosh Laskar. (2020) Implications of limited exolaryngeal disease and cricoarytenoid joint involvement in organ conservation protocols for laryngopharyngeal cancers: Results from a prospective study. Head & Neck 43:4, pages 1289-1299.
Crossref
Crossref
Hongli Gong, Liang Zhou, Haitao Wu, Lei Tao, Ming Zhang, Xiaoling Chen, Xiaoming Li, Cai Li, Jian Zhou & Shuyi Wang. (2020) Pathologic Tumor Size as a Predictor of the Survival Outcomes of Patients With Glottic Carcinoma. Otolaryngology–Head and Neck Surgery 164:2, pages 353-358.
Crossref
Crossref
Hongli Gong, Liang Zhou, Chi-Yao Hsueh, Haitao Wu, Lei Tao, Ming Zhang, Xiaoling Chen, Cai Li, Miao Mo & Jian Zhou. (2021) Prognostic value of pathological tumor size in patients with supraglottic carcinoma. American Journal of Otolaryngology 42:1, pages 102757.
Crossref
Crossref
Che-Yu Hsu, Shih-Min Lin, Ngan Ming Tsang, Yu-Hsiang Juan, Chun-Wei Wang, Wei-Chung Wang & Sung-Hsin Kuo. (2020) Magnetic resonance imaging-derived radiomic signature predicts locoregional failure after organ preservation therapy in patients with hypopharyngeal squamous cell carcinoma. Clinical and Translational Radiation Oncology 25, pages 1-9.
Crossref
Crossref
Oliver Riesterer, Martin Pruschy, Sabine Bender, Ashish Sharma, Marta Bogowicz, Stephanie Tanadini-Lang, Sonja Stieb, Kaja Bertogg, Sandra Weber, Kristian Ikenberg, Gerhard Huber, Stephan Schmid, Marius Bredell, Patrick Veit-Haibach, Tamara Rordorf, Ulrike Held, Christoph Glanzmann & Gabriela Studer. (2020) Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study. Radiotherapy and Oncology 150, pages 62-69.
Crossref
Crossref
Gabriel Adrian, Maria Gebre‐Medhin, Elisabeth Kjellén, Elinore Wieslander, Björn Zackrisson & Per Nilsson. (2020) Altered fractionation diminishes importance of tumor volume in oropharyngeal cancer: Subgroup analysis of ARTSCAN‐trial. Head & Neck 42:8, pages 2099-2105.
Crossref
Crossref
Aiqian Wu, Yongbao Li, Mengke Qi, Xingyu Lu, Qiyuan Jia, Futong Guo, Zhenhui Dai, Yuliang Liu, Chaomin Chen, Linghong Zhou & Ting Song. (2020) Dosiomics improves prediction of locoregional recurrence for intensity modulated radiotherapy treated head and neck cancer cases. Oral Oncology 104, pages 104625.
Crossref
Crossref
Letizia Ferella, Anna Cavallo, Rosalba Miceli, Nicola Alessandro Iacovelli, Tommaso Giandini, Emanuele Pignoli, Giuseppina Calareso, Paolo Bossi, Carlo Resteghini, Giovanni Luca Gravina, Piero Nicolai, Paolo Castelnuovo, Cesare Piazza, Lisa Licitra, Carlo Fallai & Ester Orlandi. (2019) Prognostic role of primary tumor, nodal neck, and retropharyngeal GTVs for unresectable sinonasal cancers treated with IMRT and chemotherapy. Tumori Journal 106:1, pages 39-46.
Crossref
Crossref
Jonathan E. Leeman, Nora Katabi, Richard J. Wong, Nancy Y. Lee & Paul B. Romesser. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
999
1033.e7
.
Jon Magne Moan, Cecilie Delphin Amdal, Eirik Malinen, Jørund Graadal Svestad, Trond Velde Bogsrud & Einar Dale. (2019) The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status. Radiotherapy and Oncology 140, pages 54-61.
Crossref
Crossref
Rushil R. Dang, Muhammad M. Qureshi, Steven J. Caldroney, Andrew R. Salama & Minh Tam Truong. (2019) Recategorization of tumor stage in patients with node‐negative oral tongue cancer: Impact of the eighth edition American Joint Committee staging system. Head & Neck 41:9, pages 2976-2982.
Crossref
Crossref
Lihong Wang, Jian Bai & Ping Duan. (2019) Prognostic value of 18F-FDG PET/CT functional parameters in patients with head and neck cancer. Nuclear Medicine Communications 40:4, pages 361-369.
Crossref
Crossref
Timo Carpén, Kauko Saarilahti, Caj Haglund, Antti Markkola, Jussi Tarkkanen, Jaana Hagström, Petri Mattila & Antti Mäkitie. (2018) Tumor volume as a prognostic marker in p16-positive and p16-negative oropharyngeal cancer patients treated with definitive intensity-modulated radiotherapyTumorvolumen als prognostischer Marker bei p16-positiven und p16-negativen Patienten mit Oropharyngealkarzinom unter Therapie mit definitiver intensitätsmodulierter Strahlentherapie. Strahlentherapie und Onkologie 194:8, pages 759-770.
Crossref
Crossref
Yun Hee Lee, Jin Ho Song, Hoon-Sik Choi, Hojin Jeong, Ki Mun Kang, Jung Hun Kang, Seung Hoon Woo, Jung Je Park, Jin Pyeong Kim & Bae Kwon Jeong. (2018) Using primary tumor volumetry to predict treatment outcome for patients with oropharyngeal cancer who were treated with definitive chemoradiotherapy. Asia-Pacific Journal of Clinical Oncology 14:2, pages e21-e28.
Crossref
Crossref
Chih-Hua Yeh, Gigin Lin, Jiun-Jie Wang, Chien-Yu Lin, Shang-Yueh Tsai, Yu-Chun Lin, Yi-Ming Wu, Sheung-Fat Ko, Hung-Ming Wang, Sheng-Chieh Chan, Tzu-Chen Yen, Chun-Ta Liao & Shu-Hang Ng. (2017) Predictive value of 1H MR spectroscopy and 18F-FDG PET/CT for local control of advanced oropharyngeal and hypopharyngeal squamous cell carcinoma receiving chemoradiotherapy: a prospective study. Oncotarget 8:70, pages 115513-115525.
Crossref
Crossref
H. Kuno, M.M. Qureshi, M.N. Chapman, B. Li, V.C. Andreu-Arasa, K. Onoue, M.T. Truong & O. Sakai. (2017) CT Texture Analysis Potentially Predicts Local Failure in Head and Neck Squamous Cell Carcinoma Treated with Chemoradiotherapy. American Journal of Neuroradiology 38:12, pages 2334-2340.
Crossref
Crossref
Cédric Panje, Oliver Riesterer, Christoph Glanzmann & Gabriela Studer. (2017) Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer. BMC Cancer 17:1.
Crossref
Crossref
M.S. Chung, Y.J. Choi, S.S. Lee, J.H. Lee, Y.S. Lee, J.L. Rho & J.H. Baek. (2017) Interobserver reproducibility of maximal axial diameter and tumour volume measurements from CT of patients with head and neck squamous cell carcinoma. Clinical Radiology 72:11, pages 993.e7-993.e13.
Crossref
Crossref
Jay C. Shiao, Abdallah S. R. Mohamed, Jay A. Messer, Katherine A. Hutcheson, Jason M. Johnson, Heiko Enderling, Mona Kamal, Benjamin W. Warren, Brian Pham, William H. Morrison, Mark E. Zafereo, Amy C. Hessel, Stephen Y. Lai, Merril S. Kies, Renata Ferrarotto, Adam S. Garden, Donald F. Schomer, G. Brandon Gunn, Jack Phan, Steven J. Frank, Beth M. Beadle, Randal S. Weber, Jan S. Lewin, David I. Rosenthal & Clifton D. Fuller. (2017) Quantitative pretreatment CT volumetry: Association with oncologic outcomes in patients with T4a squamous carcinoma of the larynx. Head & Neck 39:8, pages 1609-1620.
Crossref
Crossref
Chin Shien Lin, André Bandiera de Oliveira Santos, Evandro Lima e Silva, Leandro Luongo de Matos, Raquel Ajub Moyses, Marco Aurélio Vamondes Kulcsar, Fábio Roberto Pinto, Lenine Garcia Brandão & Claudio Roberto Cernea. (2017) Tumor volume as an independent predictive factor of worse survival in patients with oral cavity squamous cell carcinoma. Head & Neck 39:5, pages 960-964.
Crossref
Crossref
Sanne R. Martens-de Kemp, Arjen Brink, Ida H. van der Meulen, Renée X. de Menezes, Dennis E. te Beest, C. René Leemans, Victor W. van Beusechem, Boudewijn J.M. Braakhuis & Ruud H. Brakenhoff. (2017) The FA/BRCA Pathway Identified as the Major Predictor of Cisplatin Response in Head and Neck Cancer by Functional Genomics. Molecular Cancer Therapeutics 16:3, pages 540-550.
Crossref
Crossref
Gorkem Eskiizmir, Gokce Tanyeri Toker, Onur Celik, Kivanc Gunhan, Ayca Tan & Hulya Ellidokuz. (2016) Predictive and prognostic factors for patients with locoregionally advanced laryngeal carcinoma treated with surgical multimodality protocol. European Archives of Oto-Rhino-Laryngology 274:3, pages 1701-1711.
Crossref
Crossref
Kara S. Davis, Chwee Ming Lim, David A. Clump, Dwight E. Heron, James P. Ohr, Seungwon Kim, Umamaheswar Duvvuri, Jonas T. Johnson & Robert L. Ferris. (2016) Tumor volume as a predictor of survival in human papillomavirus-positive oropharyngeal cancer. Head & Neck 38:S1, pages E1613-E1617.
Crossref
Crossref
Ximena Terra, David Gómez, Jacinto García-Lorenzo, Joan Carles Flores, Enric Figuerola, Josefina Mora, Matilde R. Chacón, Miquel Quer, Mercedes Camacho, Xavier León & Francesc Xavier Avilés-Jurado. (2016) External validation of sTWEAK as a prognostic noninvasive biomarker for head and neck squamous cell carcinoma. Head & Neck 38:S1, pages E1358-E1363.
Crossref
Crossref
Brian O’Sullivan, Jatin P. Shah & William M. Lydiatt. 2016. Head and Neck Cancer. Head and Neck Cancer
181
203
.
Jesus E. Medina. 2016. Cancer of the Oral Cavity, Pharynx and Larynx. Cancer of the Oral Cavity, Pharynx and Larynx
83
112
.
Muhammad M. Qureshi, Paul B. Romesser, Abdallah Ajani, Lisa A. Kachnic, Scharukh Jalisi & Minh Tam Truong. (2016) Race disparities attributed to volumetric tumor burden in patients with head and neck cancer treated with radiotherapy. Head & Neck 38:1, pages 126-134.
Crossref
Crossref
D. Dejaco, C. Url, V. H. Schartinger, A. K. Haug, N. Fischer, D. Riedl, A. Posch, H. Riechelmann & G. Widmann. (2015) Approximation of head and neck cancer volumes in contrast enhanced CT. Cancer Imaging 15:1.
Crossref
Crossref
Mohamad Issa, Stuart Samuels, Emily Bellile, Firas Shalabi, Avraham Eisbruch & Gregory Wolf. (2015) Tumor Volumes and Prognosis in Laryngeal Cancer. Cancers 7:4, pages 2236-2261.
Crossref
Crossref
Shu-Hang Ng, Chien-Yu Lin, Sheng-Chieh Chan, Yu-Chun Lin, Tzu-Chen Yen, Chun-Ta Liao, Joseph Tung-Chieh Chang, Sheung-Fat Ko, Hung- Ming Wang, Chee-Jen Chang & Jiun-Jie Wang. (2014) Clinical Utility of Multimodality Imaging with Dynamic Contrast-Enhanced MRI, Diffusion-Weighted MRI, and 18F-FDG PET/CT for the Prediction of Neck Control in Oropharyngeal or Hypopharyngeal Squamous Cell Carcinoma Treated with Chemoradiation. PLoS ONE 9:12, pages e115933.
Crossref
Crossref
Tomasz Rutkowski. (2014) The role of tumor volume in radiotherapy of patients with head and neck cancer. Radiation Oncology 9:1.
Crossref
Crossref
Paul B. Romesser, Remy Lim, Daniel E. Spratt, Jeremy Setton, Nadeem Riaz, Benjamin Lok, Shyam Rao, Eric J. Sherman, Heiko Schöder & Nancy Y. Lee. (2014) The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [18F] fluorodeoxyglucose positron emission tomography scan. Oral Oncology 50:9, pages 802-808.
Crossref
Crossref
Daniela Oemus, Johanna Inhestern, Harald Schmalenberg, Stefan Schultze-Mosgau, Hans-Joachim Mentzel & Orlando Guntinas-Lichius. (2013) Prognostic value of tumor volumetry data of routine imaging data in a head and neck cancer registry. European Archives of Oto-Rhino-Laryngology 271:9, pages 2531-2537.
Crossref
Crossref
Li‐Jen Hsin, Tuan‐Jen Fang, Ngan‐Ming Tsang, Shy‐Chyi Chin, Tzu‐Chen Yen, Hsueh‐Yu Li, Chun‐Ta Liao & I‐How Chen. (2013) Tumor volumetry as a prognostic factor in the management of T4a laryngeal cancer. The Laryngoscope 124:5, pages 1134-1140.
Crossref
Crossref
Adam D. Yock, Arvind Rao, Lei Dong, Beth M. Beadle, Adam S. Garden, Rajat J. Kudchadker & Laurence E. Court. (2014) Predicting oropharyngeal tumor volume throughout the course of radiation therapy from pretreatment computed tomography data using general linear models. Medical Physics 41:5, pages 051705.
Crossref
Crossref
Geert O. Janssens, Liselotte W. van Bockel, Patricia A. Doornaert, Hendrik P. Bijl, Piet van den Ende, Martin A. de Jong, Guido B. van den Broek, Berit M. Verbist, Chris H. Terhaard, Paul N. Span & Johannes H. Kaanders. (2014) Computed tomography-based tumour volume as a predictor of outcome in laryngeal cancer: Results of the phase 3 ARCON trial. European Journal of Cancer 50:6, pages 1112-1119.
Crossref
Crossref
Pablo H. Montero, Frank L. Palmer, Andrew G. Shuman, Purvi D. Patel, Jay O. Boyle, Dennis H. Kraus, Luc G. Morris, Jatin P. Shah, Ashok R. Shaha, Bhuvanesh Singh, Richard J. Wong, Ian Ganly & Snehal G. Patel. (2014) A novel tumor: Specimen index for assessing adequacy of resection in early stage oral tongue cancer. Oral Oncology 50:3, pages 213-220.
Crossref
Crossref
Karen A. Eley, Stephen R. Watt-Smith, Paul Boland, Matthew Potter & Stephen J. Golding. (2014) MRI pre-treatment tumour volume in maxillary complex squamous cell carcinoma treated with surgical resection. Journal of Cranio-Maxillofacial Surgery 42:2, pages 119-124.
Crossref
Crossref
Jae Hoon Jung, Jong-Lyel Roh, Jeong Hyun Lee, Sung-Bae Kim, Sang-wook Lee, Seung-Ho Choi, Soon Yuhl Nam & Sang Yoon Kim. (2014) Prognostic factors in patients with head and neck squamous cell carcinoma with cN3 neck disease: a retrospective case-control study. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 117:2, pages 178-185.
Crossref
Crossref
Paul B. Romesser, Nadeem Riaz, Alan L. Ho, Richard J. Wong & Nancy Y. Lee. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
1037
1070.e6
.
L.W. van Bockel, E.M. Monninkhof, F.A. Pameijer & C.H.J. Terhaard. (2013) Importance of tumor volume in supraglottic and glottic laryngeal carcinomaEinfluss des Tumorvolumens beim glottischen und supraglottischen Larynxkarzinom. Strahlentherapie und Onkologie 189:12, pages 1009-1014.
Crossref
Crossref
Chan-Joo Yang, Dae-Yoon Kim, Jeong Hyun Lee, Jong-Lyel Roh, Seung-Ho Choi, Soon Yuhl Nam & Sang Yoon Kim. (2013) Prognostic value of total tumor volume in advanced-stage laryngeal and hypopharyngeal carcinoma. Journal of Surgical Oncology 108:8, pages 509-515.
Crossref
Crossref
G. Studer & C. Glanzmann. (2013) Volumetric stratification of cT4 stage head and neck cancerVolumetrische Stratifizierung von Kopf-Hals-Tumoren im cT4-Stadium. Strahlentherapie und Onkologie 189:10, pages 867-873.
Crossref
Crossref
T. Rutkowski, A. Wygoda, K. Składowski, B. Hejduk, R. Rutkowski, Z. Kołosza & B. Maciejewski. (2013) Prognostic role of tumor volume for radiotherapy outcome in patient with T2 laryngeal cancerPrognostische Bedeutung des Tumorvolumens für das Ergebnis der Strahlentherapie in Patienten mit T2-Kehlkopfkrebs. Strahlentherapie und Onkologie 189:10, pages 861-866.
Crossref
Crossref
Shu-Hang Ng, Chien-Yu Lin, Sheng-Chieh Chan, Tzu-Chen Yen, Chun-Ta Liao, Joseph Tung-Chieh Chang, Sheung-Fat Ko, Hung-Ming Wang, Shiang-Fu Huang, Yu-Chun Lin & Jiun-Jie Wang. (2013) Dynamic Contrast-Enhanced MR Imaging Predicts Local Control in Oropharyngeal or Hypopharyngeal Squamous Cell Carcinoma Treated with Chemoradiotherapy. PLoS ONE 8:8, pages e72230.
Crossref
Crossref
J.O. Brömme, M. Schmücking, A. Arnold, R. Giger, D. Rauch, D. Leiser, L. Plasswilm, A. Geretschläger, P. Ghadjar & D.M. Aebersold. (2013) Taxane-containing induction chemotherapy followed by definitive chemoradiotherapyTaxanhaltige Induktionschemotherapie gefolgt von definitiver Radiochemotherapie. Strahlentherapie und Onkologie 189:8, pages 618-624.
Crossref
Crossref
Wouter L. Lodder, Kenneth G. A. Gilhuijs, Charlotte A. H. Lange, Frank A. Pameijer, Alfons J. M. Balm & Michiel W. M. van den Brekel. (2012) Semi‐automated primary tumor volume measurements by dynamic contrast‐enhanced MRI in patients with head and neck cancer. Head & Neck 35:4, pages 521-526.
Crossref
Crossref
Gabriela Studer & Christoph Glanzmann. (2013) Volumetric staging in oropharyngeal cancer patients treated with definitive IMRT. Oral Oncology 49:3, pages 269-276.
Crossref
Crossref
Matthew C. Ward, Ling Lan, Amy Y. Chen & Jonathan J. Beitler. (2012) The value of tumor diameter in predicting prognosis of oropharynx cancer treated with chemoradiation. Oral Oncology 48:9, pages 876-880.
Crossref
Crossref
Paul B. Romesser, Muhammad M. Qureshi, Bhartesh A. Shah, Luke T. Chatburn, Scharukh Jalisi, Anand K. Devaiah, Rathan M. Subramaniam & Minh Tam Truong. (2012) Superior prognostic utility of gross and metabolic tumor volume compared to standardized uptake value using PET/CT in head and neck squamous cell carcinoma patients treated with intensity-modulated radiotherapy. Annals of Nuclear Medicine 26:7, pages 527-534.
Crossref
Crossref
Chia-Hung Kao, Shih-Chieh Lin, Te-Chun Hsieh, Kuo-Yang Yen, Shih-Neng Yang, Yao-Ching Wang, Ji-An Liang, Chun-Hung Hua & Shang-Wen Chen. (2012) Use of pretreatment metabolic tumour volumes to predict the outcome of pharyngeal cancer treated by definitive radiotherapy. European Journal of Nuclear Medicine and Molecular Imaging 39:8, pages 1297-1305.
Crossref
Crossref
Elizabeth H. Dibble, Ana C. Lara Alvarez, Minh-Tam Truong, Gustavo Mercier, Earl F. Cook & Rathan M. Subramaniam. (2012)
18
F-FDG Metabolic Tumor Volume and Total Glycolytic Activity of Oral Cavity and Oropharyngeal Squamous Cell Cancer: Adding Value to Clinical Staging
. Journal of Nuclear Medicine 53:5, pages 709-715.
Crossref
Crossref
Benjamin H. Lok, Jeremy Setton, Nicola Caria, Jonathan Romanyshyn, Suzanne L. Wolden, Michael J. Zelefsky, Jeffery Park, Nicholas Rowan, Eric J. Sherman, Matthew G. Fury, Alan Ho, David G. Pfister, Richard J. Wong, Jatin P. Shah, Dennis H. Kraus, Zhigang Zhang, Karen D. Schupak, Daphna Y. Gelblum, Shyam D. Rao & Nancy Y. Lee. (2012) Intensity-Modulated Radiation Therapy in Oropharyngeal Carcinoma: Effect of Tumor Volume on Clinical Outcomes. International Journal of Radiation Oncology*Biology*Physics 82:5, pages 1851-1857.
Crossref
Crossref
Anna Strongin, Susannah Yovino, Rodney Taylor, Jeffrey Wolf, Kevin Cullen, Ann Zimrin, Scott Strome, William Regine & Mohan Suntharalingam. (2012) Primary Tumor Volume Is an Important Predictor of Clinical Outcomes Among Patients With Locally Advanced Squamous Cell Cancer of the Head and Neck Treated With Definitive Chemoradiotherapy. International Journal of Radiation Oncology*Biology*Physics 82:5, pages 1823-1830.
Crossref
Crossref
Gabriela Studer, Tamara Rordorf & Christoph Glanzmann. (2011) Impact of tumor volume and systemic therapy on outcome in patients undergoing IMRT for large volume head neck cancer. Radiation Oncology 6:1.
Crossref
Crossref
Shih-Neng Yang, Chih-Ying Liao, Shang-Wen Chen, Ji-An Liang, Ming-Hsui Tsai, Chun-Hung Hua & Fang-Jen Lin. (2011) Clinical Implications of the Tumor Volume Reduction Rate in Head-and-Neck Cancer During Definitive Intensity-Modulated Radiotherapy for Organ Preservation. International Journal of Radiation Oncology*Biology*Physics 79:4, pages 1096-1103.
Crossref
Crossref
Kayoko OHNISHI, Yoshiyuki SHIOYAMA, Masamitsu HATAKENAKA, Katsumasa NAKAMURA, Koichiro ABE, Takashi YOSHIURA, Saiji OHGA, Takeshi NONOSHITA, Tadamasa YOSHITAKE, Torahiko NAKASHIMA & Hiroshi HONDA. (2011) Prediction of Local Failures with a Combination of Pretreatment Tumor Volume and Apparent Diffusion Coefficient in Patients Treated with Definitive Radiotherapy for Hypopharyngeal or Oropharyngeal Squamous Cell Carcinoma. Journal of Radiation Research 52:4, pages 522-530.
Crossref
Crossref
Brian O’Sullivan & Jatin P. Shah. 2011. Head and Neck Cancer. Head and Neck Cancer
135
155
.
P W Boland, S R Watt-Smith, K Pataridis, C Alvey & S J Golding. (2010) Evaluating lingual carcinoma for surgical management: what does volumetric measurement with MRI offer?. The British Journal of Radiology 83:995, pages 927-933.
Crossref
Crossref
Evangelia Peponi, Christoph Glanzmann, Guntram Kunz, Christoph Renner, Katja Tomuschat & Gabriela Studer. (2010) Simultaneous Integrated Boost Intensity‑Modulated Radiotherapy (SIB‑IMRT) in Nasopharyngeal CancerIntensitätsmodulierte Radiotherapie mit simultan integriertem Boost (SIB‑IMRT) beim Nasopharynxkarzinom. Strahlentherapie und Onkologie 186:3, pages 135-142.
Crossref
Crossref
Joost L. Knegjens, Michael Hauptmann, Frank A. Pameijer, Alfons J. Balm, Frank J. Hoebers, Josien A. de Bois, Johannes H. Kaanders, Carla M. van Herpen, Cornelia G. Verhoef, Oda B. Wijers, Ruud G. Wiggenraad, Jan Buter & Coen R. Rasch. (2010) Tumor volume as prognostic factor in chemoradiation for advanced head and neck cancer. Head & Neck, pages n/a-n/a.
Crossref
Crossref
Shang‐Wen Chen, Shih‐Neng Yang, Ji‐An Liang, Fang‐Jen Lin & Ming‐Hsui Tsai. (2009) Prognostic impact of tumor volume in patients with stage III–IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy. Head & Neck 31:6, pages 709-716.
Crossref
Crossref
Gabriela Studer, Klaus W Graetz & Christoph Glanzmann. (2008) Outcome in recurrent head neck cancer treated with salvage-IMRT. Radiation Oncology 3:1.
Crossref
Crossref
Mark J. Been, Joanna Watkins, Ryan M. Manz, Lindell R. Gentry, Glen E. Leverson, Paul M. Harari & Gregory K. Hartig. (2008) Tumor Volume as a Prognostic Factor in Oropharyngeal Squamous Cell Carcinoma Treated With Primary Radiotherapy. The Laryngoscope 118:8, pages 1377-1382.
Crossref
Crossref